Professor | Xiangpan Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xiangpan Li
Contact Information	lxp008cn@sina.com
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Xiangpan Li

Contact Information

lxp008cn@sina.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1997.06-2002.07 Bachelor of Clinical Medicine: Hubei College of Medicine 2004.09-2007.07 Master of Oncology: Guangxi Medical University 2009.09-2012.07 PhD in Oncology: Peking Union Medical College Participated in 2 National Natural Science Foundation items, 1 National Major Instrument Special Subproject, 3 provincial projects, and 1 CSCO fund
Work Experience	2002.09-2004.07 Resident Physician, Taihe Hospital, Hubei College of Medicine 2007.09-2009.07 Attending Physician in Oncology, Taihe Hospital, Hubei College of Medicine 2012.09-present Deputy Chief Physician in Radiation Oncology, Renmin Hospital, Wuhan University
Awards	2018 Medical Elite Award, Renmin Hospital, Wuhan University 2019 Medical Elite Award, Renmin Hospital, Wuhan University 2021 Medical Elite Award, Renmin Hospital, Wuhan University

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1997.06-2002.07 Bachelor of Clinical Medicine: Hubei College of Medicine
2004.09-2007.07 Master of Oncology: Guangxi Medical University
2009.09-2012.07 PhD in Oncology: Peking Union Medical College
Participated in 2 National Natural Science Foundation items, 1 National Major Instrument Special Subproject, 3 provincial projects, and 1 CSCO fund

Work Experience

2002.09-2004.07 Resident Physician, Taihe Hospital, Hubei College of Medicine
2007.09-2009.07 Attending Physician in Oncology, Taihe Hospital, Hubei College of Medicine
2012.09-present Deputy Chief Physician in Radiation Oncology, Renmin Hospital, Wuhan University

Awards

2018 Medical Elite Award, Renmin Hospital, Wuhan University
2019 Medical Elite Award, Renmin Hospital, Wuhan University
2021 Medical Elite Award, Renmin Hospital, Wuhan University

Areas of Focus	Radiation oncology Glucose metabolism and DNA damage repair
Publications	The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis, Zhao C, Xiong K, Ji Z, Liu F, Li X P, 2022 Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing, Zhao P, Zou J, Zhou F, Zhu Y, Song Q, Yu D, Li X P, 2022 LncRNA HOXC-AS1 Sponges miR-99a-3p and Upregulates MMP8, Ultimately Promoting Gastric Cancer, Jiang Y, Li X P, Yang Y, Luo J, Ren X, Yuan J, Tong Q, 2022 The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma, Li X P, Chu Y, Song Q, Hu Q, 2022 Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma, Zhao C, Xiong K, Adam A, Ji Z, Li X P, 2022 'Sandwich Therapy'-Immunotherapy Plus Concurrent Chemoradiotherapy for Advanced Esophagogastric Junction Carcinoma: Report of Two Cases and Literature Review, Wu L, Liu J, Liang L, Mao M, Li X P, Li T, Lang J, Wang Q, 2022 Synthesis of novel 4,7-disubstituted quinoline derivatives as autophagy inducing agents via targeting stabilization of ATG5, Li X P, Chen Q, Ao J, Lin W, Qiu L, Cao R, 2022 A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma, Li X P, Xiong K, Bi D, Zhao C, 2022 Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning, Zhao C, Xiong K, Zhao F, Adam A, Li X P, 2022 Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review, Li N, Xu T, Zhou Z, Li P, Jia G, Li X P*, 2022

Areas of Focus

Radiation oncology
Glucose metabolism and DNA damage repair

Publications

The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis, Zhao C, Xiong K, Ji Z, Liu F, Li X P*, 2022
Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing, Zhao P, Zou J, Zhou F, Zhu Y, Song Q, Yu D, Li X P*, 2022
LncRNA HOXC-AS1 Sponges miR-99a-3p and Upregulates MMP8, Ultimately Promoting Gastric Cancer, Jiang Y, Li X P*, Yang Y, Luo J, Ren X, Yuan J, Tong Q, 2022
The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma, Li X P, Chu Y, Song Q, Hu Q, 2022
Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma, Zhao C, Xiong K, Adam A, Ji Z, Li X P*, 2022
'Sandwich Therapy'-Immunotherapy Plus Concurrent Chemoradiotherapy for Advanced Esophagogastric Junction Carcinoma: Report of Two Cases and Literature Review, Wu L, Liu J, Liang L, Mao M, Li X P*, Li T, Lang J, Wang Q, 2022
Synthesis of novel 4,7-disubstituted quinoline derivatives as autophagy inducing agents via targeting stabilization of ATG5, Li X P, Chen Q, Ao J, Lin W, Qiu L, Cao R, 2022
A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma, Li X P, Xiong K, Bi D, Zhao C, 2022
Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning, Zhao C, Xiong K, Zhao F, Adam A, Li X P*, 2022
Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review, Li N, Xu T, Zhou Z, Li P, Jia G, Li X P*, 2022

Radiation Therapy Cancer Treatment Oncology Glucose Metabolism Dna Repair Head And Neck Cancer Glioma Lung Cancer Precision Medicine Clinical Research

Yong Huang - Wuhan University

Qingyun Wang - Wuhan University

Han Wu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us